FDIC says banks can engage in crypto activities without prior approval

FDIC says banks can engage in crypto activities without prior approval
Source link

FDIC says banks can engage in crypto activities without prior approval
Source link
Brazilian Selic Interest Rate Hiked to 13.25% from 12.25% January 30, 2025 The Central Bank of Brazil’s Selic interest rate was hiked by another full percentage point, matching the increase made at December’s meeting and bringing the cumulative rise since September to 275 basis points. At 13.25%, the new rate level is its highest since…
2025.10.24 2025.10.24 USD/JPY: Elliott Wave Analysis and Forecast for 24.10.25 – 31.10.25 Alex Geutahttps://www.litefinance.org/blog/authors/alex-geuta/ The article covers the following subjects: Major Takeaways Main scenario: Consider long positions from corrections above the level of 149.37 with a growth target of 156.50 – 158.85. A buy signal: the price holds above 149.37. Stop Loss: below 148.90, Take…
Another week, another spectacular Trump-related volatility event. After threats to the Fed Chair Powell and the Capture of the Venezuelan President, President Trump wanted some more spice. And the spice he gave: Over the weekend, the President threatened many European Nations and leaders with additional tariffs until the US can buy Greenland – a striking…
On Friday, leading derivatives marketplace CME Group announced the successful launch of its new CBL Australian Carbon Credit Unit (ACCU) futures. The new CBL Australian Carbon Credit Unit (ACCU) futures sawtotal of five contracts traded as a block between Freepoint Commodities and Mercuria on October 14, 2024, revealed CME. The new contract is designed to help…
NEW YORK, Dec 24 (Reuters) – Short interest on the New York Stock Exchange rose 2.4 percent in mid-December, the exchange said on Tuesday. As of Dec. 13, short interest rose to about 16.155 billion shares, compared with 15.784 billion shares as of Nov. 29. Investors who sell securities short borrow shares and then sell…
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth quarter…